By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novexel 



Paris      France
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Forest Laboratories, Inc. (FRX) Announces Acquisition From Novexel of Additional Rights Related to NXL 104, a Novel Broad-Spectrum Beta-Lactamase Inhibitor 12/23/2009 9:05:23 AM
AstraZeneca PLC (AZN) (JOBS) to Buy Novexel for $350 Million 12/23/2009 8:37:14 AM
Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 11/6/2009 10:02:15 AM
Novexel Presents 16 Posters and one Slide Presentation at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Meeting in San Francisco 9/11/2009 10:10:15 AM
Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki 5/18/2009 10:00:03 AM
Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush 3/26/2009 9:15:08 AM
Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs) 3/3/2009 8:25:24 AM
Novexel's NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections 11/12/2008 8:29:50 AM
Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Diseases Society of America Meeting 10/27/2008 10:47:32 AM
Novexel To Present Five Posters At The Joint Annual Interscience Conference On Antimicrobial Agents And Chemotherapy And The Infectious Disease Society Of America (ICAAC/IDSA) Meeting 10/24/2008 12:02:20 PM
12
//-->